Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type description Rank Gene Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1925 to 1974 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ornithine decarboxylase-like protein (ec 4.1.1.17) (odc-paralogue) (odc-p). [source:swissprot;acc:q96a70]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
820\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6805.86\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7540.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10801\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
orphan nuclear receptor hmr (early response protein nak1) (tr3 orphan receptor). [source:swissprot;acc:p22736]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1281\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6230.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6744.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0825\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
orphan nuclear receptor nr2e1 (nuclear receptor tlx) (tailless homolog) (tll) (htll). [source:swissprot;acc:q9y466]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1316\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6105.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6599.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08082\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
orphan nuclear receptor nr5a2 (alpha-1-fetoprotein transcription factor) (hepatocytic transcription factor) (b1-binding factor) (hb1f) (cyp7a promoter binding factor). [source:swissprot;acc:o00482]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3042\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
orphan nuclear receptor nr6a1 (germ cell nuclear factor) (gcnf) (retinoid receptor-related testis specific receptor) (rtr). [source:swissprot;acc:q15406]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
800\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6075.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6746.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1105\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
orphan nuclear receptor nurr1 (immediate-early response protein not) (transcriptionally inducible nuclear receptor). [source:swissprot;acc:p43354]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1283\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6229.16\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6742.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08246\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
orphan nuclear receptor tr2. [source:swissprot;acc:p13056]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1317\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6105.69\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6599.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0808\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
osteoclast stimulating factor 1. [source:swissprot;acc:q92882]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2542\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4708.98\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4817.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02302\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ovarian carcinoma immunoreactive antigen. [source:refseq;acc:nm\_017830]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1829\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5633.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5997\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06454\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
oxidation resistance 1. [source:refseq;acc:nm\_181354]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2138\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5859.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6173.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05369\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
oxysterols receptor lxr-alpha (liver x receptor alpha) (nuclear orphan receptor lxr-alpha). [source:swissprot;acc:q13133]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1695\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5767.69\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6165.87\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06904\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
oxysterols receptor lxr-beta (liver x receptor beta) (nuclear orphan receptor lxr-beta) (ubiquitously-expressed nuclear receptor) (nuclear receptor ner). [source:swissprot;acc:p55055]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1690\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
p protein (melanocyte-specific transporter protein). [source:swissprot;acc:q04671]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1327\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5656.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6111.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08045\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
p10-binding protein. [source:refseq;acc:nm\_024491]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1236\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5594.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6067.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08461\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
p28 ing5. [source:refseq;acc:nm\_032329]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1930\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5784.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6141.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06179\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
p29ing4; candidate tumor suppressor p33 ing1 homolog. [source:refseq;acc:nm\_016162]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1460\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5696.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6130.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07612\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
p300/cbp-associated factor (ec 2.3.1.-) (p/caf) (histone acetylase pcaf). [source:swissprot;acc:q92831]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1943\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7210.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7649.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06079\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
p47 protein isoform a. [source:refseq;acc:nm\_016143]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1467\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6444.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6932.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07572\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
p53-related protein kinase (ec 2.7.1.-) (nori-2). [source:swissprot;acc:q96s44]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1246\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5346.11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5796.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08429\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
p66 alpha. [source:refseq;acc:nm\_017660]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
353\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12839\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10911.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17669\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
paired box protein pax-6 (oculorhombin) (aniridia, type ii protein). [source:swissprot;acc:p26367]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2081\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6318.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6670.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05568\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pak1 interacting protein 1; pak1-interacting protein; pak/plc-interacting protein 1. [source:refseq;acc:nm\_017906]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3072\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pallidin; pallid (mouse) homolog, pallidin. [source:refseq;acc:nm\_012388]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
302\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5894.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7073.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.19999\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
palmitoyl-protein thioesterase 1 precursor (ec 3.1.2.22) (palmitoyl- protein hydrolase 1). [source:swissprot;acc:p50897]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2717\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5603.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5583.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00351\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
palmitoyl-protein thioesterase 2 precursor (ec 3.1.2.22) (palmitoyl- protein hydrolase 2) (ppt-2) (g14). [source:swissprot;acc:q9umr5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1477\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3687.37\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3429.37\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07523\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pantothenate kinase 1 (ec 2.7.1.33) (pantothenic acid kinase 1) (hpank1) (hpank). [source:swissprot;acc:q8te04]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
116\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
21185\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
28492\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
pantothenate kinase 2, mitochondrial precursor (ec 2.7.1.33) (pantothenic acid kinase 2) (hpank2). [source:swissprot;acc:q9bz23]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
117\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
pantothenate kinase 3 (ec 2.7.1.33) (pantothenic acid kinase 3) (hpank3). [source:swissprot;acc:q9h999]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
118\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pantothenate kinase 4 (ec 2.7.1.33) (pantothenic acid kinase 4) (hpank4). [source:swissprot;acc:q9nve7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2883\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
parafibromin. [source:refseq;acc:nm\_024529]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
894\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4331.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4771.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1016\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
paraspeckle protein 1. [source:refseq;acc:nm\_018282]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2029\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10241.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9685.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05742\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
parkinson disease (autosomal recessive, juvenile) 2, parkin isoform 1; parkin. [source:refseq;acc:nm\_004562]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
382\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4533.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5279.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16447\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
partitioning defective-6 homolog gamma (par-6 gamma) (par6d). [source:swissprot;acc:q9byg4]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
662\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6374.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7145.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12094\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pas domain containing serine/threonine kinase; pas-serine/threonine kinase. [source:refseq;acc:nm\_015148]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1634\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9899.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9251.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07011\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
paxillin. [source:swissprot;acc:p49023]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
284\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5221.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6314.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.20935\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pbk1 protein. [source:sptrembl;acc:o76021]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
838\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4064.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4493.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10559\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pc4 and sfrs1 interacting protein 2; pc4 and sfrs1 interacting protein 1; transcriptional coactivator p52/p75. [source:refseq;acc:nm\_033222]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
385\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4533.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5279.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16447\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pdz/coiled-coil domain binding partner for the rho-family gtpase tc10; fused in glioblastoma; golgi associated pdz and coiled-coil motif containing protein; cftr-associated ligand. [source:refseq;acc:nm\_020399]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2456\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5978.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6166.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03145\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pef protein with a long n-terminal hydrophobic domain (peflin). [source:refseq;acc:nm\_012392]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
426\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5942.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6853.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15325\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pepsin a precursor (ec 3.4.23.1). [source:swissprot;acc:p00790]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1178\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4392.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4776.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08732\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
peptide chain release factor 1, mitochondrial precursor (mrf-1). [source:swissprot;acc:o75570]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
880\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5166.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5694.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1023\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
peptide deformylase, mitochondrial precursor (ec 3.5.1.88) (pdf) (polypeptide deformylase). [source:swissprot;acc:q9hbh1]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2884\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
peptide methionine sulfoxide reductase (ec 1.8.4.6) (protein- methionine-s-oxide reductase) (peptide met(o) reductase). [source:swissprot;acc:q9uj68]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1106\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5489.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5986.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09046\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
peptidyl prolyl isomerase h; cyclophilin h. [source:refseq;acc:nm\_006347]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2706\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8979.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9012.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00364\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
peptidyl-prolyl cis-trans isomerase b precursor (ec 5.2.1.8) (ppiase) (rotamase) (cyclophilin b) (s-cyclophilin) (scylp) (cyp-s1). [source:swissprot;acc:p23284]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
961\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
11773\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10733.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09688\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
peptidyl-prolyl cis-trans isomerase e (ec 5.2.1.8) (ppiase e) (rotamase e) (cyclophilin e) (cyclophilin 33). [source:swissprot;acc:q9unp9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1504\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10075.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9377.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0744\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
peptidyl-prolyl cis-trans isomerase nima-interacting 1 (ec 5.2.1.8) (rotamase pin1) (ppiase pin1). [source:swissprot;acc:q13526]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1446\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5117.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5510.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07671\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
peptidylprolyl isomerase-like 4; cyclophilin-type peptidyl-prolyl cis-trans isomerase; ppiase; serologically defined breast cancer antigen ny-br-18. [source:refseq;acc:nm\_139126]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2073\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6083.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6423.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05585\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
peregrin (bromodomain and phd finger-containing protein 1) (br140 protein). [source:swissprot;acc:p55201]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2820\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
pericentrin 1; frount; nucleoporin nup75. [source:refseq;acc:nm\_024844]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3015\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/